Excitotoxicity in Neurological Diseases

Excitotoxicity in Neurological Diseases
Author :
Publisher : Springer Science & Business Media
Total Pages : 358
Release :
ISBN-10 : 9781441989598
ISBN-13 : 1441989595
Rating : 4/5 (98 Downloads)

Book Synopsis Excitotoxicity in Neurological Diseases by : Carlo Ferrarese

Download or read book Excitotoxicity in Neurological Diseases written by Carlo Ferrarese and published by Springer Science & Business Media. This book was released on 2012-12-06 with total page 358 pages. Available in PDF, EPUB and Kindle. Book excerpt: It can be reasonably anticipated that, over the next generations, the proportion of elderly people will remarkably increase and, with this, the number ofpersons suffering from acute (e.g. cerebral ischemia) or chronic neurodegenerative disorders. To date, approved drugs only alleviate the symptoms ofthese diseases (for instance, acetylcholinesterase inhibitors in Alzheimer disease and L-dopa and dopamine-agonists in Parkinson disease), while none seems to stop the progression of the degenerative processes underlying them. The development of effective preventive or protective therapies has been impeded by the limitations of our knowledge of the causes and the mechanisms by which neurons die in neurodegenerative disorders. Evidence accumulated in the past 20 years indicated that the major excitatory neurotransmitter glutamate may play a role as neurotoxin in several conditions. In particular, the glutamatergic system dysfunction seems to be an early event working as a common pathway in the pathogenesis ofa large number ofacute and chronic neurological disorders, in strict conjunction with other important mechanisms, such as oxidative stress and energetic failure, and probably triggered by different mechanisms in various diseases. In consideration of that, drug discovery efforts over the last decade have been focused on the search for drugs that either reduce glutamate synaptic levels or block its postsynaptic effects. Despite numerous reviews on basic mechanisms and clinical aspects ofthe excitotoxic phenomenon, so far no comprehensive book has covered the topic in all its complexity, starting from basic pharmacological mechanisms, to .animal models of diseases and finally to clinical pathogenic and therapeutic implications.


Excitotoxicity in Neurological Diseases Related Books

Excitotoxicity in Neurological Diseases
Language: en
Pages: 358
Authors: Carlo Ferrarese
Categories: Medical
Type: BOOK - Published: 2012-12-06 - Publisher: Springer Science & Business Media

DOWNLOAD EBOOK

It can be reasonably anticipated that, over the next generations, the proportion of elderly people will remarkably increase and, with this, the number ofpersons
Neurochemical Aspects of Excitotoxicity
Language: en
Pages: 299
Authors: Akhlaq A. Farooqui
Categories: Medical
Type: BOOK - Published: 2007-11-20 - Publisher: Springer Science & Business Media

DOWNLOAD EBOOK

Leading researchers offer cutting-edge information on glutamate metabolism in the brain, examining the role of glutamate transporters and the involvement of glu
Translational Research in Traumatic Brain Injury
Language: en
Pages: 388
Authors: Daniel Laskowitz
Categories: Medical
Type: BOOK - Published: 2016-04-21 - Publisher: CRC Press

DOWNLOAD EBOOK

Traumatic brain injury (TBI) remains a significant source of death and permanent disability, contributing to nearly one-third of all injury related deaths in th
Principles and Practice of Movement Disorders E-Book
Language: en
Pages: 557
Authors: Joseph Jankovic
Categories: Medical
Type: BOOK - Published: 2011-04-01 - Publisher: Elsevier Health Sciences

DOWNLOAD EBOOK

Principles and Practice of Movement Disorders provides the complete, expert guidance you need to diagnose and manage these challenging conditions. Drs. Stanley
Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System
Language: en
Pages: 74
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2011-08-05 - Publisher: National Academies Press

DOWNLOAD EBOOK

Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS). Despite this fact, no validated biological markers, or biomarkers, current